Table 2 The gene detection analysis during treatment
Time Gene | 2018.06.01 (baseline) | 2019.01.14 (HPD) | ||||
|---|---|---|---|---|---|---|
Plasma | Tumor Tissue | Plasma | Tumor Tissue | |||
CDKN2A PIK3CA EPHA2 KRAS | missense mutation missense mutation frameshift mutation missense mutation | 7.96% 7.87% 6.57% 4.90% | 2.36% 3.90% 3.73 - | 5.16% 4.98% 5.89% 7.97 | - 21.93% 18.24% 35.39% | |